M&A: Smith & Nephew looks to make moves

August 3, 2012 by MassDevice staff

British medical device company Smith & Nephew is still on the hunt for merger & acquisition deals.

Smith & Nephew

Smith & Nephew (FTSE:SN, NYSE:SNN) is on the hunt for buyout candidates, according to CEO Olivier Bohuon, ranging from a "bolt-on acquisition at $10 million to something much more significant."

Armed with $221 million in cash and equivalents as of June 30, the British medical device company has plenty of dry powder on hand to make its move. And Bohuon said Smith & Nephew "will borrow for the right acquisition" during a conference call yesterday.

Smith & Nephew has been actively seeking products to expand its current product offerings in minimally invasive surgery, he added.

Sign up to get our free newsletters delivered right to your inbox

SNN has been realigning for more than a year to focus growth on the emerging markets of Brazil, Russia, India and China, while creating a more streamlined operation in its existing markets. Those moves appear to be working for the company's bottom line.

Smith & Nephew posted 2nd-quarter profits of $292 million, or 33¢ per share, on sales of $1.03 billion for the 3 months ended June 30. That's a bottom-line increase of 90.8%, despite a top-line slip of 4.5%.

Adjusted to exclude 1-time items, EPS reached 18.1¢, just beating the 17.8¢ consensus estimate on Wall Street.

SNN shares gained 1.9% yesterday on the news and added half a point to that today, hitting a 52-week high of $53.50 on the way to a $52.73-per-share close on The Street and a £6.73 close in The City (where SN shares also hit a yearlong high of £6.87).